CompletedNot Applicable

The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)

Belgium300 participantsStarted 2016-09

Plain-language summary

To assess the impact of the female genital microbiome on ART outcome.

Age range18 Years – 39 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Caucasian women
✓. Women undergoing an in-vitro fertilization cycle (for the first or second time)
✓. Single embryo transfer
✓. Day 5 embryo transfer
✓. Gonadotropin-releasing hormone antagonist
✓. Anti-mullerian hormone \> 0,69 and \< 3,5 µg/L
✓. Body mass index ≤ 30 kg/m2
✓. Signed informed consent

✕. Women suffering of chronic diseases which may impair pregnancy outcome (e.g. diabetes, chronic renal disease).
✕. Antibiotics within 3 weeks of sampling
✕. Surgical sperm retrieval
✕. In-vitro maturation
✕. Preimplantation genetic diagnosis
✕. Grade 3 or 4 endometriosis
✕. Patients unable to comprehend the investigational nature of the proposed study

Clinical pregnancy

Timeframe: 7 weeks

NCT IDNCT03105453

SponsorUniversitair Ziekenhuis Brussel

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-11-02